These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

238 related articles for article (PubMed ID: 22786587)

  • 21. Diastolic heart dysfunction is correlated with CTG repeat length in myotonic dystrophy type 1.
    Park JS; Kim N; Park D
    Neurol Sci; 2018 Nov; 39(11):1935-1943. PubMed ID: 30094526
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Influence of multisystemic affection on health-related quality of life in patients with myotonic dystrophy type 1.
    Peric S; Stojanovic VR; Basta I; Peric M; Milicev M; Pavlovic S; Lavrnic D
    Clin Neurol Neurosurg; 2013 Mar; 115(3):270-5. PubMed ID: 22695270
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Clinical, psychosocial, and central correlates of quality of life in myotonic dystrophy type 1 patients.
    Laberge L; Mathieu J; Auclair J; Gagnon É; Noreau L; Gagnon C
    Eur Neurol; 2013; 70(5-6):308-15. PubMed ID: 24158106
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The hypocretin neurotransmission system in myotonic dystrophy type 1.
    Ciafaloni E; Mignot E; Sansone V; Hilbert JE; Lin L; Lin X; Liu LC; Pigeon WR; Perlis ML; Thornton CA
    Neurology; 2008 Jan; 70(3):226-30. PubMed ID: 18195268
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Prevalence and clinical correlates of sleep disordered breathing in myotonic dystrophy types 1 and 2.
    Bianchi ML; Losurdo A; Di Blasi C; Santoro M; Masciullo M; Conte G; Valenza V; Damiani A; Della Marca G; Silvestri G
    Sleep Breath; 2014 Sep; 18(3):579-89. PubMed ID: 24310756
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Sleep disorders in myotonic dystrophies.
    Subramony SH; Wymer JP; Pinto BS; Wang ET
    Muscle Nerve; 2020 Sep; 62(3):309-320. PubMed ID: 32212331
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Decreased hypocretin-1 (Orexin-A) levels in the cerebrospinal fluid of patients with myotonic dystrophy and excessive daytime sleepiness.
    Martínez-Rodríguez JE; Lin L; Iranzo A; Genis D; Martí MJ; Santamaria J; Mignot E
    Sleep; 2003 May; 26(3):287-90. PubMed ID: 12749547
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Utility and Results from a Patient-Reported Online Survey in Myotonic Dystrophies Types 1 and 2.
    Wenninger S; Stahl K; Montagnese F; Schoser B
    Eur Neurol; 2020; 83(5):523-533. PubMed ID: 33120389
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Excessive daytime somnolence and increased rapid eye movement pressure in myotonic dystrophy.
    Gibbs JW; Ciafaloni E; Radtke RA
    Sleep; 2002 Sep; 25(6):662-5. PubMed ID: 12224846
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Stapedial reflex in myotonic dystrophy type 1 and CTG repeat expansion.
    Osanai R; Kinoshita M; Hirose K
    J Neurol; 2001 Dec; 248(12):1056-61. PubMed ID: 12013582
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A review of muscle- and performance-based assessment instruments in DM1.
    Symonds T; Campbell P; Randall JA
    Muscle Nerve; 2017 Jul; 56(1):78-85. PubMed ID: 27862025
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Picturing the Experience of Living With Myotonic Dystrophy (DM1): A Qualitative Exploration Using Photovoice.
    LaDonna KA; Venance SL
    J Neurosci Nurs; 2015 Oct; 47(5):285-95. PubMed ID: 26348433
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Quality of life in patients with myotonic dystrophy type 2.
    Rakocevic Stojanovic V; Peric S; Paunic T; Pesovic J; Vujnic M; Peric M; Nikolic A; Lavrnic D; Savic Pavicevic D
    J Neurol Sci; 2016 Jun; 365():158-61. PubMed ID: 27206898
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Participation and the Role of Neuropsychological Functioning in Myotonic Dystrophy Type 1.
    Van Heugten C; Meuleman S; Hellebrekers D; Kruitwagen-van Reenen E; Visser-Meily J
    J Neuromuscul Dis; 2018; 5(2):205-214. PubMed ID: 29865086
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Responsiveness of Daytime Sleepiness and Fatigue Scales in Myotonic Dystrophy Type 1.
    Laberge L; Gallais B; Auclair J; Dauvilliers Y; Côté I; Mathieu J; Gagnon C
    Can J Neurol Sci; 2022 Mar; 49(2):287-290. PubMed ID: 33875033
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Cognitive behavioural therapy with optional graded exercise therapy in patients with severe fatigue with myotonic dystrophy type 1: a multicentre, single-blind, randomised trial.
    Okkersen K; Jimenez-Moreno C; Wenninger S; Daidj F; Glennon J; Cumming S; Littleford R; Monckton DG; Lochmüller H; Catt M; Faber CG; Hapca A; Donnan PT; Gorman G; Bassez G; Schoser B; Knoop H; Treweek S; van Engelen BGM;
    Lancet Neurol; 2018 Aug; 17(8):671-680. PubMed ID: 29934199
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Sleep disorders and fatigue in patients with different forms of myotonic dystrophy type 1].
    Erokhina EK; Melnik EA; Lebedeva DD; Shamtieva KV; Peters TV; Pavlikova EP; Gepard VV; Vlodavets DV
    Zh Nevrol Psikhiatr Im S S Korsakova; 2023; 123(8):62-67. PubMed ID: 37655412
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The proposal of a clinical protocol to assess central and peripheral fatigue in myotonic dystrophy type 1.
    Baldanzi S; Ricci G; Bottari M; Chico L; Simoncini C; Siciliano G
    Arch Ital Biol; 2017 Jul; 155(1-2):43-53. PubMed ID: 28715597
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Prevalence and predictor factors of respiratory impairment in a large cohort of patients with Myotonic Dystrophy type 1 (DM1): A retrospective, cross sectional study.
    Rossi S; Della Marca G; Ricci M; Perna A; Nicoletti TF; Brunetti V; Meleo E; Calvello M; Petrucci A; Antonini G; Bucci E; Licchelli L; Sancricca C; Massa R; Rastelli E; Botta A; Di Muzio A; Romano S; Garibaldi M; Silvestri G
    J Neurol Sci; 2019 Apr; 399():118-124. PubMed ID: 30798109
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Leukocyte CTG repeat length correlates with severity of myotonia in myotonic dystrophy type 1.
    Logigian EL; Moxley RT; Blood CL; Barbieri CA; Martens WB; Wiegner AW; Thornton CA; Moxley RT
    Neurology; 2004 Apr; 62(7):1081-9. PubMed ID: 15079005
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.